SEED Biosciences Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
2ndary - Private
- Investors
-
3
SEED Biosciences General Information
Description
Developer of single-cell dispensing technology designed for precision and efficiency in cell biology research. The company's technology provides secure handling, high cloning efficiency, traceable proof of monoclonality, and disposable tips to prevent cross-contamination, enabling researchers in life sciences to streamline workflows, meet stringent regulatory standards, and enhance experimental accuracy across applications like monoclonal antibody screening and CRISPR-mediated gene editing.
Contact Information
Website
www.seedbiosciences.comCorporate Office
- Building Serine, 3rd Floor
- Route de la Corniche 6
- 1066 Epalinges
- Switzerland
Corporate Office
- Building Serine, 3rd Floor
- Route de la Corniche 6
- 1066 Epalinges
- Switzerland
SEED Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 8. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 7. Debt - General | 15-Dec-2021 | Completed | Generating Revenue | |||
| 6. Early Stage VC (Series A) | 24-Sep-2020 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 06-Feb-2020 | Completed | Startup | |||
| 4. Accelerator/Incubator | 30-Jan-2020 | Completed | Startup | |||
| 3. Seed Round | 10-Oct-2018 | Completed | Startup | |||
| 2. Grant | 31-May-2018 | $20.1K | Completed | Startup | ||
| 1. Grant | 30-Jan-2018 | $10.4K | Completed | Startup |
SEED Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
SEED Biosciences Patents
SEED Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4508413-A1 | System and method for impedance-based analysis of biological entities | Pending | 12-Apr-2022 | ||
| US-20250251332-A1 | System and method for impedance-based analysis of biological entities | Pending | 12-Apr-2022 | ||
| WO-2023199234-A1 | System and method for impedance-based analysis of biological entities | Inactive | 12-Apr-2022 | G01N15/12 |
SEED Biosciences Signals
SEED Biosciences Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Biopole (Epalinges) | Accelerator/Incubator | |||
| Ecole Polytechnique Federale de Lausanne | University | Minority | ||
| Merck Innovation Center | Accelerator/Incubator | Minority |
SEED Biosciences FAQs
-
When was SEED Biosciences founded?
SEED Biosciences was founded in 2018.
-
Where is SEED Biosciences headquartered?
SEED Biosciences is headquartered in Epalinges, Switzerland.
-
What is the size of SEED Biosciences?
SEED Biosciences has 20 total employees.
-
What industry is SEED Biosciences in?
SEED Biosciences’s primary industry is Biotechnology.
-
Is SEED Biosciences a private or public company?
SEED Biosciences is a Private company.
-
What is SEED Biosciences’s current revenue?
The current revenue for SEED Biosciences is .
-
How much funding has SEED Biosciences raised over time?
SEED Biosciences has raised $1.78M.
-
Who are SEED Biosciences’s investors?
Biopole (Epalinges), Ecole Polytechnique Federale de Lausanne, and Merck Innovation Center have invested in SEED Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process